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Abstract: Background: Grade 2 and 3 obesity, alongside with other relevant risk factors, are substantially
and independently associated with adverse outcomes of coronavirus disease 2019 (COVID-19). However,
for Switzerland, due to the lack of synthesis studies, it is currently unknown how many people are
affected by obesity at all. This knowledge may help to better estimate the relevance and size of this
group at elevated risk, which could be incorporated into strategies to protect risk groups during the
still unfolding COVID-19 pandemic. This study aimed to provide a first overall estimation of how many
people in Switzerland are currently affected by grade 2 or 3 obesity. Methods: Five representative national
population-based studies were accessed which were conducted between 2012 and 2017 and which include
data on height and weight of adult men and women in Switzerland. Results: In Switzerland in 2012-2017,
among the 11.20% adults who were obese (body mass index (BMI) ฀30.0kg/m2), 1.76% (95% CI 1.50-2.02)
suffered from grade 2 obesity (BMI 35.0-39.9 kg/m2), and 0.58% (95% CI 0.50-0.66) from grade severe 3
obesity (BMI ฀40.0 kg/m2). Converted into estimated absolute population numbers, this corresponds to a
total of approximately n=154,515 people who suffer from grade 2 or 3 obesity (n=116,216 and n=38,298,
respectively). Conclusions: This risk group includes many younger people in Switzerland. The number
of people with obesity-related risk becomes 3.8 to 13.6 times higher if grade 1 obesity and overweight
people are also included in this risk group, for which there are arguments arising in the latest literature.
In general, this large group at risk for severe COVID-19 should be given more attention and support.
If it is confirmed that obesity plays a major role in severe COVID-19 courses, then every kilo of body
weight that is not gained or that is lost in lockdown counts
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Background: Grade 2 and 3 obesity, alongside with other relevant risk 
factors, are substantially and independently associated with adverse 
outcomes of coronavirus disease 2019 (COVID-19). However, for 
Switzerland, due to the lack of synthesis studies, it is currently 
unknown how many people are affected by obesity at all. This 
knowledge may help to better estimate the relevance and size of this 
group at elevated risk, which could be incorporated into strategies to 
protect risk groups during the still unfolding COVID-19 pandemic. This 
study aimed to provide a first overall estimation of how many people 
in Switzerland are currently affected by grade 2 or 3 obesity. 
Methods: Five representative national population-based studies were 
accessed which were conducted between 2012 and 2017 and which 
include data on height and weight of adult men and women in 
Switzerland. 
Results: In Switzerland in 2012-2017, among the 11.20% adults who 
were obese (body mass index (BMI) ≥30.0kg/m2), 1.76% (95% CI 1.50-2.02) suffered from grade 2 obesity (BMI 35.0-39.9 kg/m2), and 0.58% (95% CI 0.50-0.66) from grade severe 3 obesity (BMI ≥40.0 kg/m2). Converted into estimated absolute population numbers, this corresponds to a total of approximately n=154,515 people who suffer from grade 2 or 3 obesity (n=116,216 and n=38,298, respectively). 
Conclusions: This risk group includes many younger people in 
Switzerland. The number of people with obesity-related risk becomes 
3.8 to 13.6 times higher if grade 1 obesity and overweight people are 
also included in this risk group, for which there are arguments arising 
in the latest literature. In general, this large group at risk for severe 
COVID-19 should be given more attention and support. If it is 
confirmed that obesity plays a major role in severe COVID-19 courses, 
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Introduction
In Fall 2020, severe acute respiratory syndrome coronavirus 2 
(SARS-CoV-2) has Europe firmly in its grip again, and 
Switzerland, like its neighboring countries, is experiencing a 
strong second wave. Because the virus is now spreading again, 
it is important to provide better protection for people at ele-
vated risk of developing severe courses of coronavirus disease 
2019 (COVID-19). However, this can only be done if such 
risk groups are better defined and identified.
Over the last months, the evidence base has become increasingly 
strong that obesity, alongside with other relevant risk factors, is 
substantially and independently associated with adverse 
outcomes of COVID-19 (Lockhart & O’Rahilly, 2020). A system-
atic review and pooled analysis of 75 studies recently confirmed 
that individuals with obesity were more at risk for COVID-19 
positive, for hospitalization, for ICU admission, and for mor-
tality (Popkin et al., 2020). In the largest analyzed cohort study 
to date significantly increased risks of COVID-19-related 
death were seen for obesity grade 3 (body mass index (BMI) 
≥40.0kg/m2) and grade 2 (BMI 35.0–39.9kg/m2), but not 
for obesity grade 1 (BMI 30.0–34.9kg/m2) and overweight 
(BMI 25.0–29.9kg/m2) (Williamson et al., 2020).
Beyond that, it has been shown that the association between 
obesity and COVID-19 is independent of diabetes and other 
diseases frequently associated with obesity and the metabolic 
syndrome, meaning that also so-called “healthy” obese people 
might be at elevated risk of severe COVID-19 (Beretta, 2020; 
Tartof et al., 2020). Switzerland seems to be no exception: 
For example, obesity was a significant part of the high burden 
of comorbidities in a sample of patients hospitalized with 
COVID-19 at the cantonal hospital Aarau (Switzerland) in 
Spring 2020 (Gregoriano et al., 2020). Thus, two pandemics 
are currently intertwining (Lockhart & O’Rahilly, 2020), the 
communicable one of COVID-19 and the non-communicable 
one of obesity, both affecting significant parts of the population 
in Switzerland.
However, for Switzerland, due to the lack of synthesis studies, 
it is currently not clear how many people – in relative and 
absolute numbers – are actually affected by obesity at all, and 
thus have an increased risk of a severe COVID-19 course. There 
are a handful of individual representative population-based 
studies conducted between 2012 and 2017, but there are no 
overall estimates. Consequently, we aim to provide a first over-
all estimate of how many people in Switzerland are currently 
affected by grade 2 and 3 obesity. Such estimations may help to 
better estimate the relevance and size of this group at elevated 
risk, which could be incorporated into strategies to protect risk 
groups during the still unfolding COVID-19 pandemic.
Methods
We accessed five representative national population-based 
studies which were conducted between 2012 and 2017 and which 
include data on height and weight of adult men and women in 
Switzerland (Table 1). All five studies are based on representa-
tive samples and provide official sample weightings which allow 
to correct for non-participation. For all data sets we included 
only adults aged 18 years and older.
The Swiss Health Survey (SHS) is a representative survey of 
the health status, health behavior and use of health services of 
the Swiss population and has been conducted every five years 
since 1992. In the present study, the waves 2012 (SHS12, 
n=21,597 participants) and 2017 (SHS17, n=21,597 participants) 
were included. Both survey years were analyzed separately. 
A detailed description of the data collection, the recruitment 
procedure, the participation rate and the strategy of sample 
weighting was published elsewhere (Bundesamt für Statistik, 
2014; Storni et al., n.d.). The SHS data were provided by the 
Federal Statistical Office (FSO). The Swiss Household Panel 
(SHP) is a representative longitudinal study of the social changes 
and living conditions of the Swiss population and has been 
conducted annually since 1999 with three samples (1999, 2004 
and 2013). This study used cross-sectional data from the third 
sample from 2013 (n=5,040 participants). A detailed description 
Table 1. Included representative studies.
Study Acronym Years Age 
range
n
Swiss Health Survey1 SHS12 2012 15–75 21597
Swiss Health Survey1 SHS17 2017 15–75 22134
Swiss Household Panel2 SHP 2013 14–85 5040
Swiss National Nutrition Survey3 menuCH 2014/2015 18–75 2057
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of the data collection, the recruitment process, the participa-
tion rate and the strategy of sample weighting was published 
elsewhere (Voorpostel et al., 2020). The SHP data are avail-
able from the Swiss Centre of Expertise in the Social Sciences 
(FORS) website. menuCH is the first representative national 
nutrition survey of Switzerland conducted between 2014 and 
2015 (n=2,057 participants). A detailed description of the data 
collection, weighting strategy, the recruitment process and the 
participation rate is published elsewhere (Bochud et al., 2017; 
Pasquier et al., 2017). The data were provided by the Federal 
Food Safety and Veterinary Office (FSVO). The Swiss Survey 
on Income and Living Conditions (SILC) is a representa-
tive study of income and living conditions of Swiss households. 
Households are surveyed over several years and new house-
holds are added each year. This study uses cross-sectional data 
from 2017 (n=12,980 participants). A detailed description of the 
data collection, the recruitment procedure, the participation rate 
and the strategy of sample weighting was published elsewhere 
(Schweiz. Bundesamt für Statistik BFS, 2014). The SILC data 
were provided by the Federal Statistical Office (FSO). Since all 
five data sets are publicly accessible for research purposes and 
are fully anonymized, no ethics permission was required for 
the present study.
With the exception of menuCH (where body height and body 
weight were also measured) the data sets contain exclusively 
self-reported height and weight information. Based on height 
and weight we calculated BMI (kg/m2). Very few people with 
a BMI <14.0 or >60.0 kg/m2 were excluded. Thereafter, BMI 
was categorized according to the WHO groups for underweight 
(BMI <18.5 kg/m2), normal-weight (18.5–24.9 kg/m2), pre-
obesity (25.0–29.9 kg/m2), obesity grade 1 (30.0–34.9 kg/m2), 
obesity grade 2 (35.0–39.9 kg/m2), and obesity grade 3 
(≥40.0 kg/m2) (World Health Organization (WHO), 2020).
Statistical analysis
The relative frequency or proportion of the BMI categories 
were calculated for each of the five studies. We used official 
sample weights provided by the data owners, but we did not 
adjust these estimated proportions for potential cofactors, mainly 
because we were interested in an overall estimation of the 
prevalence in Switzerland. To estimate the overall proportion 
we averaged the weighted proportions across all five data sets 
and calculated 95% confidence intervals via standard deviations. 
To estimate the absolute number of affected people in each of 
the BMI categories in all of the five studies individually we 
used official population numbers for adults in the corresponding 
survey years as denominator (Schweiz. Bundesamt für Statistik 
BFS, 2020). To estimate the overall estimation of relative fre-
quencies of the BMI groups we averaged the yearly population 
numbers 2012–2017. The statistical analyses were performed 
using R Version 3.6.0 (R Core Team, 2018). Stata version 14 
(Stata Corporation, College Station, TX, USA) was used for all 
analyses and graphs.
Results
Our overall estimation shows that in Switzerland in 2012–2017, 
31.72 % (95% CI 31.07-32.37) of the adult population were 
affected by overweight (BMI 25.0–29.9kg/m2) (Table 2). 
Of the 11.20% who were obese (BMI ≥30.0kg/m2), 8.86% 
(95% CI 8.30-9.42) suffered from grade 1 obesity (BMI 
30.0–34.9 kg/m2), 1.76% (95% CI 1.50-2.02) from grade 2 
obesity (BMI 35.0–39.9 kg/m2), and 0.58% (95% CI 0.50-0.66) 
from grade severe 3 obesity (BMI>=40.0 kg/m2). Converted into 
estimated absolute population numbers, this corresponds to a total 
of approximately n=154,515 people who suffer from grade 2 or 
3 obesity (n=116,216 and n=38,298, respectively). Overall, an 
estimated total of n=2,834,088 or 42.92% of the adult population 
in Switzerland are overweight or obese (BMI>=25.0 kg/m2).
Table 3 shows the convergence across the individually esti-
mated relative frequencies from each of the five analyzed 
surveys. The proportion for grade 2 obesity ranged between 1.5% 
and 2.2%, and for grade 3 obesity between 0.5% and 0.7%. The 
highest relative frequencies for all three grades of obesity were 
calculated for the menuCH data.
Table 2. Overall estimation of the prevalence of World Health 
Organization (WHO) body mass index (BMI) categories across 
all 5 included representative data sets. To calculate the absolute 
numbers the average number of the adult residential population in 
Switzerland from the survey years 2012–2017 (n=6,603,188) was used 
as a denominator.




underweight (<18.5) 2.82 (2.46- 3.18) 186210
normal (18.5 – 24.9) 54.28 (53.57-54.99) 3584211
pre-obesity (25.0 – 29.9) 31.72 (31.07-32.37) 2094531
obesity I (30.0 – 34.9) 8.86 (8.30- 9.42) 585042
obesity II (35.0 – 39.9) 1.76 (1.50- 2.02) 116216
obesity III (≥ 40.0) 0.58 (0.50- 0.66) 38298
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The stratification by sex shows that men were more affected 
by overweight and grade 1 obesity (Figure 1 and Table 4. 
However, for grade 2 and 3 obesity, there is a weak tendency 
towards women being slightly more affected. Although there 
is an increase in the proportion in all overweight and obesity 
(sub-)categories with increasing age, there are still considerable 
proportions of younger adults (aged 18–35 years) who suf-
fer from obesity grade 2 (1.04%, 95%CI 0.43-1.65) or grade 3 
(0.44%, 95%CI 0.11-0.77).
Discussion
We show that the proportion of people in Switzerland who 
suffer from grade 2 or 3 obesity and thus an increased risk of 
severe COVID-19 course seems small in terms of percentages 
(2.34%), but when converted into absolute numbers it translates 
into a considerable number of human lives. At least 150,000 
adults in Switzerland suffer from grade 2 or grade 3 obesity and 
are thus at elevated risk for adverse outcomes of COVID-19. 
This also includes many younger people in Switzerland.
It goes without saying that the causes of severe COVID-19 are 
only fragmentarily understood at this time (Pairo-Castineira 
et al., 2020) and that obesity frequently coincides with other risk 
factors for severe COVID-19 such as male sex, older age, dia-
betes, elevated blood pressure, and other comorbidities. How-
ever, recent studies suggest, that the association between obesity 
and severe COVID-19 is independent from these other cofac-
tors, and experts debate diverse pathways and mechanisms 
which link both pandemics. It should be mentioned that an 
increased risk for disease severity among grade 3 obese people 
is already well documented for influenza, especially in past 
pandemics such as the Swine flu of 2009 (Morgan et al., 2010).
Among the possible explanations that link obesity with severe 
COVID-19 disease, the following pathways are currently men-
tioned in the literature: First, there are mechanical reasons 
which can worsen the prognosis in hospitals, as obesity is known 
to be associated with reduced lung volume/function, restricted 
airflow, and poor response to mechanical ventilation (Caci et al., 
2020; Wadman, 2020). Second, obesity can be related to other 
complications, such as renal failure, cardiovascular dysfunction, 
hypertension, blood clotting, and vascular damage, which in turn 
can further influence negative outcomes of COVID-19 (Caci 
et al., 2020; Frühbeck et al., 2020). Third, the biological and 
physiological pathways probably include obesity-driven chronic 
low-grade inflammation and metabolically dysregulated immune 
response to infection, which may drive organ injury in the 
development of severe COVID-19 and impair viral clearance 
(Caci et al., 2020; Chiappetta et al., 2020; Frühbeck et al., 2020; 
Huizinga et al., 2020; Smith et al., 2020; Wadman, 2020). 
However, other factors are currently proposed as well, such 
as links to fat embolism (Cinti et al., 2020) or growth hormone 
insufficiency (Lubrano et al., 2020). Finally, behavioral and 
social aspects could also play a role: People suffering from 
obesity may delay seeking medical care due to fear of being 
stigmatized which could increase their likelihood of severe 
COVID-19 (Wadman, 2020). However, this would still have to 
be verified for Switzerland on the basis of hospitalization datas 
around the lockdown in spring 2020.
By October 2020, the Federal Office of Public Health declares 
that only people with grade 3 obesity (BMI>=40.0kg/m2, 
meaning weighting at least 126kg for an average tall man of 
178cm or at least 111kg for an average tall women of 166cm) 
have an increased risk of severe COVID-19 (Bundesamt für 
Gesundheit (BAG), 2020). However, this rather narrow definition 
of an obesity-related risk group probably needs to be extended 
based on recent evidence being published: In a large sample 
from Paris, all three grades of obesity doubled mortality in 
patients hospitalized with Covid-19 (Czernichow et al., 2020), 
and in another large UK sample there was an upward linear trend 
in the likelihood of COVID-19 hospitalization with increasing 
BMI, that was evident already in overweight people (BMI 
25.0–29.9kg/m2) (Hamer et al., 2020). The same pattern was 
documented in New York, where an increased risk of dying 
from COVID-19 was not only found in obese but also in 
Table 3. Estimation of the prevalence of World Health Organization (WHO) body 
mass index (BMI) categories for each of the 5 included representative data sets. 
The provided sample weights were used, but the estimations were not adjusted for 
cofactors.
BMI WHO categories SHS 2012 SHS 2017 SHP 2013 menuCH 
2014/2015
SILC 2017
underweight (<18.5) 3.3 2.9 2.9 2.3 2.7
normal (18.5 – 24.9) 54.7 55.2 54.3 53.9 53.3
pre-obesity (25.0 – 29.9) 31.9 31.2 31.3 31.4 32.8
obesity I (30.0 – 34.9) 8.1 8.5 9.4 9.4 8.9
obesity II (35.0 – 39.9) 1.6 1.7 1.5 2.2 1.8
obesity III (≥ 40.0) 0.5 0.5 0.6 0.7 0.6
SHS - Swiss Health Survey, SHP - Swiss Household Panel, menuCH - Swiss National Nutrition Survey, 
SILC - Statistics on Income and Living Conditions
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Figure 1. Overall estimation of the prevalence (incl. 95% CI) of World Health Organization (WHO) body mass index (BMI) 
categories across all 5 included representative data sets, stratified by sex (left column) and age groups (right column). The 
vertical dashed lines indicate the overall estimations from Table 1. The precise results can be found in Table 4.
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overweight people with a BMI 25.0–29.9kg/m2 (Nakeshbandi 
et al., 2020). In our studies of large samples of conscripts for the 
Swiss Armed Forces, i.e. data with a high coverage for young 
and mostly healthy men, we show that, on the one hand, inflam-
matory blood parameters (CRP, leukocytes, neutrophils and 
basophils) (Staub et al., 2018) and, on the other hand, endurance 
performance (VO2max) (Gassmann et al., 2020) do not sud-
denly increase or decrease only with obesity (BMI ≥30.0kg/m2), 
but gradually increase with increasing BMI, even within the 
overweight BMI range (25.0–29.9kg/m2).
In sum, based on international studies, there is increasing 
evidence that grade 1 obesity and overweight are also associ-
ated with adverse COVID-19 outcomes. If this is confirmed, 
then significantly more people in Switzerland (approximately 
585,042 with grade 1 obesity and 2,094,531 with overweight) 
would be exposed to this increased risk. However, as long as 
most studies virtually dichotomize BMI (obese vs. non-obese) 
and do not model it continuously and even non-linearly, it will 
remain unclear whether many more people with lighter forms 
of obesity and overweight are also at elevated risk. It would also 
be important in this context to go beyond BMI and also inves-
tigate other anthropometric proxies for body fat distribution, 
as it has recently been shown that patients with visceral adi-
posity or high intramuscular fat deposition have a particularly 
higher risk for critical COVID-19 illness and should be 
monitored more carefully when hospitalized (Yang et al., 2020).
Our study comes with limitations: First, the BMI is not an 
ideal measure of body composition because it cannot distinguish 
between muscle and fat in terms of weight. Nevertheless, at a 
population level, BMI is still strongly correlated with body 
fat (Keys et al., 1972; Kit et al., 2014). Second, in four of the 
five studies included, information on height and weight was 
self-reported. In Switzerland, too, it has already been confirmed 
that men in particular report being taller than they are (espe-
cially with increasing age) and women, on the other hand, assess 
themselves less heavy (Faeh et al., 2009; Faeh et al., 2008; 
Vinci et al., 2019a). In both cases this would mean rather 
under- than overestimation of overweight and obesity levels in 
our analysis. In the case of the menuCH data, we observed that 
the overall proportions for the BMI categories according to 
WHO differ only marginally when comparing the measured with 
the self-reported BMI values. We did therefore not adjust our 
analysis for this potential bias. Third, population-based health 
surveys can be subjected to a healthy and higher education 
Table 4. Overall estimation of the prevalence of World Health Organization (WHO) body mass 




BMI WHO categories Proportion in % (95% CI) Proportion in % (95% CI)
underweight (<18.5) 0.70 (0.50-0.90) 4.84 (4.08- 5.60)
normal (18.5 – 24.9) 46.34 (44.06-48.62) 62.04 (60.09-63.99)
pre-obesity (25.0 – 29.9) 40.76 (39.39-42.13) 22.86 (21.25-24.47)
obesity I (30.0 – 34.9) 10.26 (9.32-11.20) 7.48 (6.73-8.23)
obesity II (35.0 – 39.9) 1.54 (1.18-1.90) 1.96 (1.70-2.22)
obesity III (≥ 40.0) 0.40 (0.28-0.52) 0.78 (0.48-1.08)
B) Age groups
18–35y 36–55y >55y
BMI WHO categories Proportion in % (95% CI) Proportion in % 
(95% CI)
Proportion in % 
(95% CI)
underweight (<18.5) 4.08 (2.25-5.91) 2.04 (1.45- 2.63) 2.08 (1.65- 2.51)
normal (18.5 – 24.9) 64.66 (58.93-70.39) 53.68 (51.38-55.98) 45.28 (43.10-47.46)
pre-obesity (25.0 – 29.9) 24.00 (20.06-27.94) 32.50 (31.11-33.89) 37.88 (36.60-39.16)
obesity I (30.0 – 34.9) 5.76 (3.23-8.29) 9.26 (7.96-10.56) 11.90 (10.39-13.41)
obesity II (35.0 – 39.9) 1.04 (0.43-1.65) 1.76 (1.42-2.10) 2.24 (2.08-2.40)
obesity III (≥ 40.0) 0.44 (0.11-0.77) 0.78 (0.57-0.99) 0.60 (0.48-0.72)
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participation bias, meaning that participants in such surveys are 
generally slightly healthier and better educated than the gen-
eral population (Bopp et al., 2014; Volken, 2013). The last two 
listed limitations, measured anthropometrics and participant bias 
might be among the reasons why in menuCH the proportions 
of overweight and obese participants was slightly higher than 
in the other four included surveys. Apart from the comparably 
small sample size and the relatively low participation rate 
(38%), one of menuCH’s special features is that among the over-
weight (7.2%), and especially among the obese participants 
(14.1%), there are comparatively many people who have stated 
that they are on a weight-loss diet (Vinci et al., 2019b). This 
might be related to the fact that there was increased interest 
in a nutrition survey among these participants, which led to a 
slight increase in the participation rate, especially among obese 
people. However, the applied sample weights do not adjust 
for this participation bias.
Conclusion
Because synthesis studies have been lacking until now, it 
was unclear how large the group of adults is in Switzerland, 
which has an increased risk of a severe COVID-19 course due to 
obesity. We have shown in this publication: This affects at least 
150,000 adult people in Switzerland with grade 2 or 3 obesity. 
However, these numbers are 3.8 to 13.6 times higher if grade 1 
obesity and overweight people are also included in this risk 
group, for which there are arguments arising in the latest litera-
ture. Relative and absolute numbers provide relevant but differ-
ent perspectives. We think that especially in a pandemic, in 
which communication via numbers is so dominant, it is impor-
tant not to lose the relation to the absolute numbers, especially 
when it concerns human lives.
The health emergency caused by the COVID-19 pandemic 
currently diverts attention from the prevention and care of 
non-communicable chronic diseases, such as obesity, to com-
municable diseases (Dicker et al., 2020). It is important to focus 
increasingly on the interlinks between the two pandemics, because 
obviously in this case a communicable and a non-communica-
ble pandemic are linked. Professional societies such as European 
Association for the Study of Obesity (EASO) are currently 
developing position statements and guidelines on the manifold 
challenges for obese people during this COVID-19 pandemic 
(Frühbeck et al., 2020).
We think that two fields of action are particularly important: 
A) Current NCD prevention programs aimed at preventing 
weight gain in the general population should be continued or 
even intensified, despite the current focus on infectious diseases. 
B) The numerous people who also suffer from obesity in 
Switzerland should be given more attention and support. This 
applies not only to obese people who are infected with the virus, 
but to this numerous group in general, as stigmatization, lock-
downs, stress, anxiety, or isolation have many consequences for 
health behaviors and well-being on various levels, especially 
in such vulnerable groups with preconditions (Frühbeck et al., 
2020). A particular challenge for such public health programs 
at various levels is certainly that overweight and obese people 
are not a homogenous group, as we have shown in our previous 
work (Vinci et al., 2019b), and specific subgroups might 
need specifically tailored approaches. Regionally and socially 
differentiated public health strategies are very important in 
identifying these risk groups, especially if one has to react 
quickly and with limited resources. However, the effort might 
be worth it: If the current scientific state of knowledge becomes 
more and more solid and obesity really does play that major 
role in severe COVID-19 courses, then every kilo of body 
weight that is not gained in lockdowns or that is lost counts 
(Beretta, 2020). It might even be doubly worth the effort, as 
obesity is known to be a risk factor for other factors such as 
cardiovascular diseases or diabetes, which are themselves (inde-




The five data sets on which this paper is based are owned and 
administered by the Federal Food Safety and Veterinary Office 
(FSVO) and the Federal Office of Public Health (FOPH). Based 
on signed data contracts the authors of this paper are not author-
ized to share the individual data. However, all studies used 
can be accessed by other researchers via standard procedures 
requested by the FSVO (webpage menuCH), the FOPH (web-
page SILC, webpage SHS), and FORS (webpage SHP), thus all 
results of this paper can easily be replicated.
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Übergewicht und Adipositas. Neuchatel. 2014.  
Reference Source
	 Caci	G,	Albini	A,	Malerba	M,	et al.: COVID-19 and Obesity: Dangerous Liaisons. 
J Clin Med. 2020; 9(8): 2511.  
PubMed Abstract | Publisher Full Text | Free Full Text 
 Chiappetta S, Sharma AM, Bottino V, et al.: COVID-19 and the role of chronic 
inflammation in patients with obesity. Int J Obes (Lond). 2020; 44(8):  
1790–1792.  
PubMed Abstract | Publisher Full Text | Free Full Text 
	 Cinti	S,	Graciotti	L,	Giordano	A,	et al.: COVID-19 and fat embolism: a 
hypothesis to explain the severe clinical outcome in people with obesity. 
Int J Obes (Lond). 2020; 44(8): 1800–1802.  
PubMed Abstract | Publisher Full Text | Free Full Text 
 Czernichow S, Beeker N, Rives-Lange C, et al.: Obesity Doubles Mortality in 
Patients Hospitalized for Severe Acute Respiratory Syndrome Coronavirus 
2 in Paris Hospitals, France: A Cohort Study on 5,795 Patients. Obesity (Silver 
Spring). 2020; 28(12): 2282–2289.  
PubMed Abstract | Publisher Full Text | Free Full Text 
	 Dicker	D,	Bettini	S,	Farpour-Lambert	N,	et al.: Obesity and COVID-19: The Two 
Sides of the Coin. Obes Facts. 2020; 13(4): 430–438.  
PubMed Abstract | Publisher Full Text 
 Faeh D, Braun J, Bopp M: Underestimation of obesity prevalence in 
Switzerland: comparison of two methods for correction of self-report. Swiss 
Med Wkly. 2009; 139(51–52): 752–756.  
PubMed Abstract 
 Faeh D, Marques-Vidal P, Chiolero A, et al.: Obesity in Switzerland: do 
estimates depend on how body mass index has been assessed? Swiss Med 
Wkly. 2008; 138(13–14): 204–210.  
PubMed Abstract 
	 Frühbeck	G,	Baker	JL,	Busetto	L,	et al.: European Association for the Study of 
Obesity Position Statement on the Global COVID-19 Pandemic. Obes Facts. 
2020; 13(2): 292–296.  
PubMed Abstract | Publisher Full Text | Free Full Text 
	 Gassmann	NN,	Matthes	KL,	Eppenberger	P,	et al.: Residential Altitude 
Associates With Endurance but Not Muscle Power in Young Swiss Men. 
Front Physiol. 2020; 11: 860.  
PubMed Abstract | Publisher Full Text | Free Full Text 
	 Gregoriano	C,	Koch	D,	Haubitz	S,	et al.: Characteristics, predictors and 
outcomes among 99 patients hospitalised with COVID-19 in a tertiary care 
centre in Switzerland: an observational analysis. Swiss Med Wkly. 2020; 150: 
w20316.  
PubMed Abstract | Publisher Full Text 
	 Hamer	M,	Gale	CR,	Kivimäki	M,	et al.: Overweight, obesity, and risk of 
hospitalization for COVID-19: A community-based cohort study of adults in 
the United Kingdom. Proc Natl Acad Sci. 2020; 117(35): 21011–21013.  
PubMed Abstract | Publisher Full Text | Free Full Text 
	 Huizinga	GP,	Singer	BH,	Singer	K:	The Collision of Meta-Inflammation and 
SARS-CoV-2 Pandemic Infection. Endocrinology. 2020; 161(11):	bqaa154.	
PubMed Abstract | Publisher Full Text | Free Full Text 
	 Keys	A,	Fidanza	F,	Karvonen	MJ,	et al.: Indices of relative weight and obesity.  
J Chronic Dis. 1972; 25(6): 329–43.  
PubMed Abstract | Publisher Full Text 
	 Kit	BK,	Ogden	CL,	Flegal	KM:	Epidemiology of Obesity. In: Ahrens, W., Pigeot, I. 
(Eds.),	Handbook of Epidemiology. Springer Science+Business Media, New York, 
2014; 2229–2262.  
Publisher Full Text 
	 Lockhart	SM,	O’Rahilly	S:	When Two Pandemics Meet: Why Is Obesity 
Associated with Increased COVID-19 Mortality? Med (N Y). 2020.  
PubMed Abstract | Publisher Full Text | Free Full Text 
	 Lubrano	C,	Masi	D,	Risi	R,	et al.: Is Growth Hormone Insufficiency the Missing 
Link Between Obesity, Male Gender, Age, and COVID-19 Severity? Obesity 
(Silver Spring). 2020; 28(11): 2038–2039.  
PubMed Abstract | Publisher Full Text | Free Full Text 
	 Morgan	OW,	Bramley	A,	Fowlkes	A,	et al.: Morbid Obesity as a Risk Factor 
for Hospitalization and Death Due to 2009 Pandemic Influenza A(H1N1) 
Disease. PLoS One. 2010; 5(3): e9694.  
PubMed Abstract | Publisher Full Text | Free Full Text 
	 Nakeshbandi	M,	Maini	R,	Daniel	P,	et al.: The impact of obesity on COVID-19 
complications: a retrospective cohort study. Int J Obes (Lond). 2020; 44(9):  
1832–1837.  
PubMed Abstract | Publisher Full Text | Free Full Text 
	 Pairo-Castineira	E,	Clohisey	S,	Klaric	L,	et al.: Genetic mechanisms of critical 
illness in Covid-19. medRxiv. 2020.  
Publisher Full Text 




	 Popkin	BM,	Du	S,	Green	WD,	et al.: Individuals with obesity and COVID‐19: A 
global perspective on the epidemiology and biological relationships. Obes 
Rev. 2020; 21(11): e13128.  
PubMed Abstract | Publisher Full Text | Free Full Text 
 R Core Team: R: A language and environment for statistical computing.  
R Foundation for Statistical Computing, Vienna, Austria. 2018.  
Reference Source
 Schweiz. Bundesamt für Statistik BFS: Altersmasszahlen der ständigen 
Wohnbevölkerung nach Staatsangehörigkeitskategorie und Geschlecht, 
2012-2017 [WWW Document]. 2020.  
Reference Source
 Schweiz. Bundesamt für Statistik BFS: Quality report based on 2014 EU-SILC 
cross-sectional data, Switzerland. 2014.  
Reference Source
	 Smith	M,	Honce	R,	Schultz-Cherry	S:	Metabolic Syndrome and Viral 
Pathogenesis: Lessons from Influenza and Coronaviruses. J Virol. 2020; 
94(18): e00665–20.  
PubMed Abstract | Publisher Full Text | Free Full Text 
	 Staub	K,	Henneberg	M,	Galassi	FM,	et al.: Increasing variability of body mass 
and health correlates in Swiss conscripts, a possible role of relaxed natural 
selection? Evol Med Public Health. 2018; 2018(1): 116–126.  
PubMed Abstract | Publisher Full Text | Free Full Text 
	 Storni	M,	Lieberherr	R,	Kaeser	M:	Schweizerische Gesundheitsbefragung 
2017. Bundesamt für Statistik, Neuchâtel. n.d. 
Reference Source
	 Tartof	SY,	Qian	L,	Hong	V,	et al.: Obesity and Mortality Among Patients 
Diagnosed With COVID-19: Results From an Integrated Health Care 
Organization. Ann Intern Med. 2020; 173(10): 773–781.  
PubMed Abstract | Publisher Full Text | Free Full Text 
	 Vinci	L,	Floris	J,	Koepke	N,	et al.: Have Swiss adult males and females stopped 
growing taller? Evidence from the population-based nutrition survey 
menuCH, 2014/2015. Econ Hum Biol. 2019a; 33: 201–210.  
PubMed Abstract | Publisher Full Text 
	 Vinci	L,	Krieger	JP,	Braun	J,	et al.: Clustering of sociodemographic and lifestyle 
factors among adults with excess weight in a multilingual country. 
Nutrition.	2019b;	62: 177–185.  
PubMed Abstract | Publisher Full Text 
 Volken T: Second-stage non-response in the Swiss health survey: 
determinants and bias in outcomes. BMC Public Health. 2013; 13: 167. 
PubMed Abstract | Publisher Full Text | Free Full Text 
	 Voorpostel	M,	Tillmann	R,	Lebert	F,	et al.: Swiss Household Panel Userguide 
(1999-2018), Wave 20, February 2020. FORS,	Lausanne.	2020.	
 Wadman M: Why COVID-19 is more deadly in people with obesity—even if 
they’re young. Science (80-. ). 2020.  
Reference Source
	 Williamson	EJ,	Walker	AJ,	Bhaskaran	K,	et al.: Factors associated with COVID-
19-related death using OpenSAFELY. Nature. 2020; 584(7821): 430–436. 
PubMed Abstract | Publisher Full Text 
	 World	Health	Organization	(WHO):	Body Mass Index.	[WWW	Document].	2020.	
Reference Source
 Yang Y, Ding L, Zou X, et al.: Visceral Adiposity and High Intramuscular Fat 
Deposition Independently Predict Critical Illness in Patients with SARS‐
CoV‐2. Obesity (Silver Spring). 2020; 28(11): 2040–2048.  
PubMed Abstract | Publisher Full Text | Free Full Text 
Page 9 of 10
F1000Research 2020, 9:1413 Last updated: 07 DEC 2020
The benefits of publishing with F1000Research:
Your article is published within days, with no editorial bias•
You can publish traditional articles, null/negative results, case reports, data notes and more•
The peer review process is transparent and collaborative•
Your article is indexed in PubMed after passing peer review•
Dedicated customer support at every stage•
For pre-submission enquiries, contact research@f1000.com
Page 10 of 10
F1000Research 2020, 9:1413 Last updated: 07 DEC 2020
